Alzheimer's disease & dementia

Experts challenge FDA over approval for new dose of Alzheimer's drug

Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today.

Oncology & Cancer

Hong Kong's first anti-cancer drug granted with US FDA IND

(Medical Xpress) -- The discovery of a new drug for liver cancer by researchers of The Hong Kong Polytechnic University (PolyU) and local medical practitioner has born fruit. After completing clinical trials locally, the ...

Medications

US seeks injunction on Indian drug firm Ranbaxy

US officials sought a "groundbreaking" injunction against Indian drug giant Ranbaxy on Wednesday, saying the maker of the first generic version of cholesterol-lowering Lipitor has failed to meet US safety guidelines.

page 2 from 7